Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alfred Sandrock Insider Profile
4 Followers
Alfred Sandrock, Head of Research & Development at Biogen, holds 322.84K shares in Voyager Therapeutics (Ticker: VYGR), holds 10.17K shares in Biogen (Ticker: BIIB), holds 0.00 shares in Neurocrine (Ticker: NBIX). Most recently, Alfred Sandrock Sold ― shares of Voyager Therapeutics on Apr 03, 2024 for an estimated value of 119.45K.
Alfred Sandrock Biogen (BIIB)Head of Research & Development
Biogen (BIIB)
Head of Research & Development
Ranked #42,803 out of 99,335 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+3.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Alfred Sandrock holds in companies
Most Profitable Insider Trade
The most profitable trade made by Alfred Sandrock
Alfred Sandrock's Trading History
Biogen
Jun 09, 2021
Head of Research & Development
Uninformative Sell
3.38M
$1.61M
Voyager Therapeutics
Apr 03, 2024
President & CEO, Director
Informative Sell
119.45K
$1.75M
Neurocrine
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Alfred Sandrock's performance on stock
You May Also Like
Alfred Sandrock insider profile FAQ
What is the percentage of profitable transactions made by Alfred Sandrock?
The percentage of profitable transactions made by Alfred Sandrock is 67%.
What is the average return per transaction made by Alfred Sandrock?
The average return per transaction made by Alfred Sandrock is 3.30%.
What stocks does Alfred Sandrock hold?
Alfred Sandrock holds: BIIB, VYGR, NBIX stocks.
What was Alfred Sandrock’s latest transaction?
Alfred Sandrock latest transaction was an Informative Sell of $119.45K.
What was Alfred Sandrock's most profitable transaction?
Alfred Sandrock’s most profitable transaction was an Informative Sell of VYGR stock on April 3, 2024. The return on the trade was 23.70%.
What is Alfred Sandrock's role in Biogen?
Alfred Sandrock's role in Biogen is Head of Research & Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.